ROCEPHIN

This brand name is authorized in Ecuador, Hong Kong, Ireland, Japan, Mexico, Singapore, United Kingdom, South Africa

Active ingredients

The drug ROCEPHIN contains one active pharmaceutical ingredient (API):

1 Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM

Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death. Read about Ceftriaxone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Rocephin 250mg, 1g and 2g vials	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 15.586-3-07-05
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 39790, 44048, 44067
Country: HK	Department of Health Drug Office	Identifier(s): 20188, 20190, 20195, 52844
Country: IE	Health Products Regulatory Authority	Identifier(s): 57983, 57992
Country: JP	医薬品医療機器総合機構	Identifier(s): 6132419F1020, 6132419F2026, 6132419G1025
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 098M84, 104M84
Country: SG	Health Sciences Authority	Identifier(s): 00388P, 00566P
Country: ZA	Health Products Regulatory Authority	Identifier(s): R/20.1.1/44, R/20.1.1/45, R/20.1.1/46, R/20.1.1/47